HIMS
Hims & Hers Health, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth +11.8% ·
share flow +13.7% ·
net new positions +10.5%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 116 | +5 | 113.70M | $3.93B | +12 | −9 |
| Q1 2026 | 116 | -11 | 106.84M | $2.21B | +5 | −17 |
| Q4 2025 | 126 | 0 | 156.98M | $5.10B | +3 | −2 |
| Q3 2025 | 18 | -3 | 142.80M | $8.10B | +1 | −5 |
| Q2 2025 | 19 | +2 | 90.37M | $4.50B | +2 | n/a |
| Q1 2025 | 14 | 0 | 34.98M | $1.03B | +1 | −1 |
| Q4 2024 | 14 | 0 | 32.53M | $786.65M | +1 | −1 |
| Q3 2024 | 13 | -1 | 22.65M | $417.14M | n/a | −1 |
| Q2 2024 | 14 | n/a | 23.02M | $464.79M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 24.75M | n/a | $1.23B | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 2 | The Vanguard Group ✦ (passive) | 18.67M | n/a | $930.85M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Capital World Investors ✦ | 18.56M | New | $925.18M | 0.1% | New | 1 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passive) | 7.04M | -5.4% | $350.99M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 6.87M | -2.2% | $342.44M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 4.75M | +1.5% | $236.62M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 1.89M | -68.7% | $94.07M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 1.58M | +84.9% | $78.65M | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 9 | Norges Bank ✦ (passive) | 1.57M | -33.8% | $78.46M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.13M | +71.7% | $56.36M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 1.09M | n/a | $54.11M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 12 | Bridgewater Associates ✦ | 598.03K | -19.9% | $29.81M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 568.97K | -71.1% | $28.36M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 563.88K | -13.1% | $28.11M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 390.11K | +204.7% | $19.19M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 16 | Millennium Management ✦ | 187.57K | -86.0% | $9.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Marshall Wace ✦ | 105.45K | -59.7% | $5.26M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 46.20K | -94.4% | $2.30M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 18.99K | New | $946,801 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Capital World Investors | $925.18M | 0.1% |
| Gotham Asset Management | $946,801 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 430 holders, 143.91M shares, $2.91B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 3.46K sh · $100,577
Officer · 3.46K sh · $100,957
Officer · 29.28K sh · $876,846
Officer · 12.31K sh · $354,861
Officer · 6.24K sh · $173,735
Officer · 14.03K sh · $398,227
Officer · 7.95K sh · $225,814
Officer · 3.46K sh · $97,965
Officer · 4.94K sh · $148,111
Officer · 25.11K sh · $691,808
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
9.4% of class · View original SEC filing ↗